Doesn’t matter if Pona can do it better. Your only hope of ARIA’s attaining a $20B valuation by the end of the decade is if CML remains a disease that requires chronic treatment for almost all patients.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.